These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30237273)
21. [Utility of 8-colours multiparameter flow cytometry immunophenotyping of plasma cells for the management of monoclonal gammopathy]. Gressier M; Chaquin M; Lhermitte L; Asnafi V; Macintyre E; Brouzes C Ann Biol Clin (Paris); 2013; 71(3):313-23. PubMed ID: 23747669 [TBL] [Abstract][Full Text] [Related]
22. [Monoclonal gammopathy of undetermined significance]. Chaïbi P; Merlin L; Thomas C; Piette F Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832 [TBL] [Abstract][Full Text] [Related]
23. [Monoclonal gammapathy of indeterminate origin and myeloma]. Bury J; Salmon J; Fillet G Rev Med Liege; 1988 Apr; 43(8):270-4. PubMed ID: 3285431 [No Abstract] [Full Text] [Related]
24. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control. Paiva B; Vídriales MB; Rosiñol L; Martínez-López J; Mateos MV; Ocio EM; Montalbán MÁ; Cordón L; Gutiérrez NC; Corchete L; Oriol A; Terol MJ; Echeveste MA; De Paz R; De Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Granell M; Gorosquieta A; Alegre A; Orfao A; Lahuerta JJ; Bladé J; San Miguel JF; Leukemia; 2013 Oct; 27(10):2056-61. PubMed ID: 23743858 [TBL] [Abstract][Full Text] [Related]
25. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Kyle RA; Rajkumar SV Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088 [TBL] [Abstract][Full Text] [Related]
26. A case study progression to multiple myeloma. Yancey MA; Waxman AJ; Landgren O Clin J Oncol Nurs; 2010 Aug; 14(4):419-22. PubMed ID: 20682498 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients. González-Calle V; Mateos MV Eur J Intern Med; 2018 Dec; 58():57-63. PubMed ID: 29907380 [TBL] [Abstract][Full Text] [Related]
28. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma. Hidalgo Lopez JE; Yabe M; Carballo-Zarate AA; Wang SA; Jorgensen JL; Ahmed S; Lee J; Li S; Schlette E; McDonnell T; Miranda RN; Medeiros LJ; Bueso-Ramos CE; Yin CC J Natl Compr Canc Netw; 2016 Aug; 14(8):939-44. PubMed ID: 27496109 [TBL] [Abstract][Full Text] [Related]
29. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias. Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491 [TBL] [Abstract][Full Text] [Related]
31. A case of concomitant T-cell large granular lymphocyte leukemia and plasma cell myeloma. Nawaz U; Baidas S; Jones E Clin Adv Hematol Oncol; 2011 Dec; 9(12):956-7. PubMed ID: 22252668 [No Abstract] [Full Text] [Related]
32. Overview of monoclonal gammopathies of undetermined significance. Vogt RF; Marti GE Br J Haematol; 2007 Dec; 139(5):687-9. PubMed ID: 18021082 [TBL] [Abstract][Full Text] [Related]